PNH - Traveling with a Rare Disease - Update from Josh
Person's Name:
Joshua Maliczowski
Traveling with a rare disease
Bone Marrow Disease(s):
Content source:
treatment
Beat AML Master Clinical Trial Showcases Paradigm Shift With Precision Medicine
Crovalimab
An experimental complement inhibitor C5 monoclonal antibody.
Guang-Shing Cheng, M.D.
Cheng, Guang-Shing
Associate Professor
Fred Hutchinson Cancer Research Center
Online Profile:
Staci Arnold, MD, MBA, MPH
Arnold, Staci
Assistant Professor of Pediatrics
Children's Healthcare of Atlanta
Online Profile:
Treatment Approaches in AML: Key Testing for Personalized Care
VIDEO
Description:
Treatment Approaches in AML: Key Testing for Personalized Care from Patient Empowerment Network on Vimeo.
Talati Highlights “Game-Changing” Potential of Venetoclax/HMA Combos for Elderly AML
Chetasi Talati, MD, discusses early results from a multicenter chart review examining treatment patterns and outcomes of patients with newly diagnosed AML who received venetoclax/HMA combinations in the real-world setting and the next phase of the ongoing research initiative.
Chetasi Talati, MD
Chetasi Talati, MD
ASH Issues Guidelines on Newly Diagnosed AML in Older Adults
MDS Treatment, Inqovi: Dr. Amer Zeidan Explains the Use of this Treament
The recently-approved hypomethylating treatment, Inoqvi, is a daily oral version of two IV or subcutaneous medications. Listen to Dr. Amer Zeidan of Yale Cancer Center explain which MDS patients could qualify, and what it means for their treatment at the link.